Heilongjiang Weikang Bio-Tech Group

What Heilongjiang Weikang Bio-Tech Group does

Heilongjiang Weikang Bio-Tech Group is a Harbin, China-based entity whose public record shows it was founded in 2004 and was previously listed on the NYSE under ticker WKBT before being delisted; firmographic data describes it as engaged in the R&D of advanced health-keeping products. Two funding rounds totaling approximately $5 million were recorded in 2010. The data carries a material discrepancy: the active web presence at hljweikang.com presents 密战剧场 (Secret War Theater), a free consumer streaming platform for Chinese spy and drama television series, which is not consistent with a biotech/health-products business and may indicate a domain redirect, rebrand, or mislabeled entity record.

Operating under the 密战剧场 brand, the platform offers free 1080P HD streaming of over 5,000 titles across 50+ categories, with synchronized Chinese subtitles and multi-device playback across mobile, tablet, and smart TV. Distribution is digital-first via direct web access and downloadable apps, targeting individual Chinese-speaking consumers interested in domestic spy/drama content. The revenue model is stated as fully free with no subscriptions, advertising, or premium tiers disclosed, and no financial metrics are published.

Leadership is limited to a single named executive (CEO Wang Yin). There is no disclosed management team, ownership structure, investor base, or partnership network. Customer concentration, monetization mechanics, and operational scale are unverified beyond self-reported user engagement claims (12.8M+ registered users, 9.2 platform rating), leaving the commercial viability and true identity of the business unclear from the available evidence.

Name

Heilongjiang Weikang Bio-Tech Group

Legal name

密战剧场

Website

https://hljweikang.com

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

11–50 employees

Short description

Heilongjiang Weikang Bio-Tech Group is a Harbin, China-based, formerly NYSE-listed entity (ticker WKBT, now delisted) whose active web domain operates 密战剧场, a free Chinese spy/drama streaming platform serving individual Chinese-speaking consumers across mobile, tablet, and TV.

Ownership category

akta.pro rank

Product category

Online Video Streaming

NAICS

Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers (516210)

SIC

Services-Motion Picture & Video Tape Distribution (7822)

akta.pro industry

PRIMARYBPAMAJAB

Live Streaming & Webcasting Platforms

Business & Public Services/Web, Mobile & Digital Platforms/Media Streaming, Publishing & Content Platforms

SECONDARYMPAHAJAB

Subscriber Identity, Entitlements & Access (SSO, IAM, Paywall)

Media, Entertainment & Sports/Media Technology & Services (Post-Production, VFX, Animation, Streaming Infrastructure)/OTT/Streaming Platform Technology (CMS, Player SDKs, Apps)

SECONDARYMPAHAJAI

DRM, License Delivery & Content Protection (Widevine/FairPlay/PlayReady)

Media, Entertainment & Sports/Media Technology & Services (Post-Production, VFX, Animation, Streaming Infrastructure)/OTT/Streaming Platform Technology (CMS, Player SDKs, Apps)

Keywords

• Video streaming service
• Chinese drama content
• Spy drama series
• HD video streaming
• Online entertainment platform

Headquarters

HQ city

Harbin

HQ country

China

HQ region

Asia

Markets served

GTM type

B2C

Offering type

Digital Commerce or Content

Cost components

Technology or R&D, Supply Chain, Operations, Infrastructure, Personnel

Revenue model

1. Free Streaming Service: All video content is provided completely free of charge with no subscription fees, pay-per-view charges, or premium tier upgrades. The platform generates no disclosed revenue streams.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels3 records

Core offering

Heilongjiang Weikang Bio-Tech Group operates an online video streaming platform branded as 密战剧场 (Secret War Theater) that provides free 1080P HD streaming of Chinese spy and drama television series with synchronized Chinese subtitles. The platform aggregates over 5,000 titles across 50+ categories, claims 12.8 million+ registered users, and offers multi-device synchronization across mobile, tablet, and television. All content is provided at no cost to individual viewers.

Product overview

密战剧场 (Secret War Theater) is a unified streaming platform serving as the company's core product. The platform provides free online streaming of Chinese spy/drama TV series in 1080P HD quality with Chinese subtitles, featuring content curation with daily updates, multi-device synchronization support, and user rating features. The platform aggregates over 5,000 titles across 50+ categories targeting Chinese drama enthusiasts, with stated registration of 12.8 million users and a 9.2 platform rating.

Differentiator

Problem solved

Functional benefit

Products and services

• 密战剧场 (Secret War Theater) Streaming Platform

Quantifiable outcome

• 12.8 million+ registered users
• +1 more outcomes

Segments3 records

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights3 records

Direct peers

• Rakuten Viki: Asian drama and movie streaming service with community-subtitled content and multi-device support. Closely comparable because it delivers subtitled Asian (including Chinese) dramas to international audiences with a free ad-supported tier and paid options — a business model and content focus highly aligned with the subject.
• Bilibili: Chinese video community and streaming platform combining licensed anime/drama content with creator-driven video. Comparable as a Chinese-language video streaming destination with multi-device viewing and a strong enthusiast community similar to the subject's spy-drama fan base.

Broad incumbents

• iQiyi: One of China's largest OTT streaming platforms operated by Baidu, offering licensed movies, TV dramas (including spy dramas), and originals. Comparable to the subject company because it serves Chinese consumers seeking on-demand drama content, but with vastly larger scale, paid tiers, and licensed catalog.
• Tencent Video: Tencent's OTT streaming platform with a large catalog of licensed Chinese dramas, originals, and exclusive content. Comparable in serving Chinese viewers seeking on-demand spy/drama content with multi-device support.
• Mango TV: Hunan Broadcasting System's OTT streaming platform offering licensed Chinese dramas, variety shows, and originals. Comparable as a Chinese-language drama streaming service targeting similar consumer segments.
• Youku: Alibaba-owned Chinese video streaming service offering licensed TV series, films, and originals. Directly comparable as a Chinese-language drama streaming destination serving overlapping viewer segments.
• Sohu Video: Sohu's long-standing Chinese video streaming service offering licensed TV dramas, films, and originals. Comparable as a Chinese-language drama streaming destination competing for the same viewer base.

Regional players

• Viu: PCCW-operated Asian content streaming service offering licensed Korean, Chinese, and Japanese dramas with subtitles across multiple Asian markets. Comparable as a subtitled Asian drama streaming platform targeting similar content interests in a different geographic footprint.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Heilongjiang Weikang Bio-Tech Group